Role of EDHF in type 2 diabetes-induced endothelial dysfunction - Wikidata - wikimedia - TriplyDB

Role of EDHF in type 2 diabetes-induced endothelial dysfunction

Role of EDHF in type 2 diabetes-induced endothelial dysfunction

http://www.wikidata.org/entity/Q37038962

about

The role of epoxyeicosatrienoic acids in the cardiovascular system Insulin resistance and endothelial dysfunction: Are epoxyeicosatrienoic acids the link?An ethanolic extract of Lindera obtusiloba stems, YJP-14, improves endothelial dysfunction, metabolic parameters and physical performance in diabetic db/db mice Regulation of Microvascular Function by Adipose Tissue in Obesity and Type 2 Diabetes: Evidence of an Adipose-Vascular Loop.Erythropoietin enhances hydrogen peroxide-mediated dilatation of canine coronary collateral arterioles during myocardial ischemia in dogs in vivo.Vascular dysfunction associated with type 2 diabetes and Alzheimer's disease: a potential etiological linkage.Effects of interventions on oxidative stress and inflammation of cardiovascular diseases Cardiovascular physiology at the bench for application in the clinic.The endothelium: influencing vascular smooth muscle in many ways.Terminal arteriolar network structure/function and plasma cytokine levels in db/db and ob/ob mouse skeletal muscle.Effect of PAR2 in regulating TNF-α and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice.Eicosanoids, β-cell function, and diabetes Exercise training improves endothelial function via adiponectin-dependent and independent pathways in type 2 diabetic mice.Preserved arterial vasodilatation via endothelial protease-activated receptor-2 in obese type 2 diabetic mice Role of endothelium-dependent hyperpolarisation and prostacyclin in diabetes.Neurovascular microcirculatory vasodilation mediated by C-fibers and Transient receptor potential vanilloid-type-1 channels (TRPV 1) is impaired in type 1 diabetes Endothelium-Derived Hyperpolarization and Coronary Vasodilation: Diverse and Integrated Roles of Epoxyeicosatrienoic Acids, Hydrogen Peroxide, and Gap Junctions.Role of TNF-alpha in vascular dysfunction.Exacerbation of endothelial dysfunction during the progression of diabetes: role of oxidative stress Proteolytic receptor cleavage in the pathogenesis of blood rheology and co-morbidities in metabolic syndrome. Early forms of autodigestion.Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice.Exercise training enhances multiple mechanisms of relaxation in coronary arteries from ischemic hearts.Role of inflammation in the regulation of coronary blood flow in ischemia and reperfusion: mechanisms and therapeutic implications.Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update.Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease--an overview.Endothelial calcium-activated potassium channels as therapeutic targets to enhance availability of nitric oxide.Interactions between thromboxane A₂, thromboxane/prostaglandin (TP) receptors, and endothelium-derived hyperpolarization.Physical activity opposes coronary vascular dysfunction induced during high fat feeding in mice.Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome.A New Hypothesis for Insulin Resistance in Hypertension Due to Receptor Cleavage.Endothelial dysfunction in renal arcuate arteries of obese Zucker rats: The roles of nitric oxide, endothelium-derived hyperpolarizing factors, and calcium-activated K+ channels The Role of Endoplasmic Reticulum Stress in Cardiovascular Disease and Exercise.Regulation of Coronary Endothelial Function by Interactions between TNF-α, LOX-1 and Adiponectin in Apolipoprotein E Knockout Mice.Endothelium-derived hyperpolarizing factor and diabetes.Interaction of IL-6 and TNF-α contributes to endothelial dysfunction in type 2 diabetic mouse hearts.Anti-diabetic atherosclerosis effect of Prunella vulgaris in db/db mice with type 2 diabetes.Weight and inflammation are the major determinants of vascular dysfunction in the aortae of db/db mice.Coronary microvascular dysfunction after long-term diabetes and hypercholesterolemia.Hyperglycaemia disrupts conducted vasodilation in the resistance vasculature of db/db mice.

P2860

Q28256560-C002B822-F7F1-432C-B683-5A744336D51E Q28390132-5D343460-013C-408B-8360-94C8FAA7DDE9 Q28533586-E9A11C71-7CEC-47DE-A47A-22D33302B4AC Q33602767-F42CE883-02C3-4C62-86CE-D84C29EE5F25 Q33703498-FD04B044-6D16-438B-9418-6D283BD72B9E Q34066200-DCD12B91-CA64-43EB-A500-CE251C7E9163 Q34538729-5D42C376-6061-488A-B711-0ACDDDC3387E Q34635118-26C3245C-CA0A-41D3-9189-BCDFB5D53022 Q34638538-2B7ECDAA-3305-4553-BC60-6F1A1BFD860B Q34842420-CAFE6FF5-E973-40A7-B8E0-581179547031 Q35128047-C6B73E74-B62E-46DB-8248-7BDF9ED9BB31 Q35129888-D2A6008A-3743-434A-86D2-6E5E8956A24F Q35159911-13EB937C-BD85-4D79-8CBF-619684B5DE7A Q35216480-A2E10D4E-F0AD-4435-AFD3-ADC06D68AD1F Q35625597-22CAEEFD-17D6-48BE-A395-26520AA8A8AB Q36305870-0B30E12B-F95D-45FF-A423-FFED47134E55 Q36450226-371EF2CF-5EFA-4698-AA5D-062C9A9EE361 Q37050343-7C2E6E57-8E7C-40BA-9A8F-74810F7EA30A Q37175490-8BB6F36C-1ECF-4D0C-A08F-37AA388527C6 Q37228621-25E095F2-72F1-4993-AAA2-7698C6604F8D Q37341923-1973C773-E188-4628-A6A2-3F4E66F501DD Q37342069-AAE6B192-1ED7-4FA5-8CD1-836821A8BBC4 Q37933583-F492F908-8C85-4F67-83D3-E0A27FAF9C7D Q37960812-F0E48ABE-4ED3-4EAD-BD60-7DDA39079090 Q37970585-62B09A11-A8CB-4835-9331-0FF8E8978036 Q37991017-424431D3-8395-4AA9-B66E-7E303F1B2944 Q38012853-4235DB13-6EE5-454C-AE1B-14E083D62099 Q38182425-8D7EB795-96A2-479F-85CF-3AEA4018CC97 Q38324686-DA857968-3B55-464B-A6E1-A18F03E1898E Q39430910-58DA4AE1-35A4-4C25-8826-CFE0A3A872B1 Q41343627-76C2637A-5ACD-4E0C-B7BF-E9C613090E6D Q41443651-ED2DE374-44B5-4C3A-A260-029C6200A7A5 Q41508828-7997B831-E4A8-4008-A5C7-6008CB66972E Q41649163-9FB39E0C-B143-490A-A02E-153A2A9BEE1B Q41813606-96953F02-75DF-4ED6-8ED7-8463FC6B5D07 Q47121775-083A9319-813F-4BF5-A7DA-B268003E0E38 Q47212408-5E455B45-1641-4DFE-A558-8FD0E9C0C870 Q47388151-D6B663EE-7858-4790-899A-AA3B0DF66961 Q48371916-5EB2B5EE-0529-40E2-899B-8EC1E7387760 Q50021398-ABB4F8BB-7FEC-42B6-B708-58B0514CFDCA

P2860

Role of EDHF in type 2 diabetes-induced endothelial dysfunction

http://www.wikidata.org/entity/Q37038962

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Role of EDHF in type 2 diabetes-induced endothelial dysfunction

@en

Role of EDHF in type 2 diabetes-induced endothelial dysfunction.

@nl

type

label

Role of EDHF in type 2 diabetes-induced endothelial dysfunction

@en

Role of EDHF in type 2 diabetes-induced endothelial dysfunction.

@nl

prefLabel

Role of EDHF in type 2 diabetes-induced endothelial dysfunction

@en

Role of EDHF in type 2 diabetes-induced endothelial dysfunction.

@nl

P1433

Q37038962-E93E8BD8-7754-44E0-9DA0-10CCA39A858F

P1476

Q37038962-87F59CC7-9C73-413A-9487-18AE0440C7F5

P2093

Q37038962-5212FC11-AC08-48D2-BE8E-19930F588BD0

Q37038962-5668432A-43FE-4E59-8BF0-AC01D1E359E6

Q37038962-A52DF794-CA2E-4EBB-8F0E-A9B3D6B00E7B

Q37038962-A5BBC62A-C607-492D-A6EC-7CC193A78918

Q37038962-C1B9AE14-872B-4249-A9D1-D0CD2724F601

Q37038962-EA8DD72F-0C43-43C2-98A3-9417FF0F6950

P2860

Q37038962-06B001DF-5C7B-4213-B0AE-F055B5981B6C

Q37038962-09AFB4FD-B045-407A-93B9-77B82412E5FB

Q37038962-0C9D2629-20AE-43CD-A0E4-A9A76F2A4EB8

Q37038962-17A0CE09-922D-43B9-8828-72DAF09876ED

Q37038962-188FAE4E-9B93-4B78-B485-E4EA07A92B40

Q37038962-2490EFAD-0453-427A-804C-920501CAF689

Q37038962-29A4B2E4-E797-44E8-9E79-5A915C62D5DB

Q37038962-36863435-022C-49A3-9172-115F33B87F10

Q37038962-38A06088-7C8E-4632-8AC5-8EB9446BCC73

Q37038962-51D7CCDF-54D5-4E53-97A7-65B019591156

P304

Q37038962-3E3E2B73-F605-4B32-ACB8-3E081E171721

P31

Q37038962-104354BA-D782-4755-9539-CA20F98B9C4D

P356

Q37038962-DBFD44F4-3F30-46D9-95C8-DA16B0C02612

P433

Q37038962-B6508414-556A-46FB-8194-570D6B1FB38C

P478

Q37038962-12E241EE-7B45-4299-970D-021C503EF2D9

P577

Q37038962-8204C73E-9794-4F4A-B6D2-41689682A1CF

P5875

Q37038962-F0FFCEFB-E554-4192-937B-76F117B0A8F6

P698

Q37038962-EB91DC4A-C81E-4CA7-BC61-6F3B85C965F9

P921

Q37038962-65F15239-95ED-48CB-A955-96E9B53A5A9A

Q37038962-79700A2A-A8C9-475F-987D-87B94E0D40A7

P932

Q37038962-14C34506-921E-4E60-BCA9-622204FB7A03

P356

AJPHEART.01261.2007

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Role of EDHF in type 2 diabetes-induced endothelial dysfunction

@en

P2093

Cuihua Zhang

http://www.w3.org/2001/XMLSchema#string

John R Falck

http://www.w3.org/2001/XMLSchema#string

Kevin C Dellsperger

http://www.w3.org/2001/XMLSchema#string

Stefano Capobianco

http://www.w3.org/2001/XMLSchema#string

Xue Gao

http://www.w3.org/2001/XMLSchema#string

Yoonjung Park

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo.

The alternative: EDHF.

Endothelial dysfunction in diabetes.

Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.

Characterization of an apamin-sensitive small-conductance Ca(2+)-activated K(+) channel in porcine coronary artery endothelium: relevance to EDHF

Characterization of a charybdotoxin-sensitive intermediate conductance Ca2+-activated K+ channel in porcine coronary endothelium: relevance to EDHF.

P304

H1982-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.01261.2007

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

295

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23256747

http://www.w3.org/2001/XMLSchema#string

P698

18790831

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

2614585

http://www.w3.org/2001/XMLSchema#string